Public Comments for: HB625 - Health insurance; limit on cost-sharing payments for prescription drugs under certain plans.
NABIP supports patient access to prescription drugs but opposes mandates that increase health plan costs. Experience shows that cost‑sharing caps shift expenses into higher premiums, which disproportionately affect small employers and working families in Virginia. The National Association of Benefits and Insurance Professionals represents more than 100,000 licensed health insurance agents, brokers, general agents, consultants and benefit professionals through more than 200 chapters across America. NABIP members service the health insurance needs of large and small employers as well as people seeking individual health insurance coverage.
The document attached is a letter of support for HB625 from members of the State Access to Innovative Medicines (SAIM) Coalition.
On behalf of the Association for Clinical Oncology (ASCO), I submit the attached one-pager highlighting the financial challenges patients with cancer experience. We thank the Subcommittee for your work to address the financial barriers to cancer care.
On behalf of the Association for Clinical Oncology (ASCO), I'm pleased to submit a letter in support of HB 625. Please don't hesitate to reach out if you have questions about cancer care; we're happy to be a resource.
Please, vote for this bill. The average Virginian spends about $1,500-$2,000 in prescription drug costs and some surveys have shown that 1 in 4 Virginian's skipped taking their meds due to prescription drug costs. As oral chemo because an increasing option for treating cancer patients in remission, the bill will help keep necessary medicine accessible for those in need. Again, please vote for this bill.
Please see comments attached.